Knight Capital Urges Short-Selling Leniency for U.S.

New Post Public Reply Private Reply Replies (0) Message Board
MaxShockeR

Knight Capital Urges Short-Selling Leniency for U.S. Stock Market Makers

Regulators should consider giving market makers more latitude to sell stock short to ease the burden of increased obligations that may be imposed on those firms, according to an executive at Knight Capital Group Inc.

Market makers sometimes can’t sell stock in response to demand because some securities that aren’t actively traded are hard to borrow, Jamil Nazarali, global head of the electronic trading group at Knight Capital Group Inc., said at a Security Traders Association conference in Washington on Sept. 24.

“More latitude around being able to short stock” would offer market makers relief, Nazarali said. Brokers that make markets by providing bids and offers for investors to trade with should be allowed to maintain short sales for longer than the current period, he said. In a short sale, borrowed shares are sold with the aim of profiting by later buying back the stock at a lower price.

The U.S. Securities and Exchange Commission is considering new obligations and benefits for market makers to ensure that sufficient liquidity is available in times of volatility. SEC Chairman Mary Schapiro has said the agency may give market makers new benefits that will entice them to accept heftier commitments following the May 6 plunge that briefly erased $862 billion in U.S. equity value in less than 20 minutes.

“When an investor wants to buy certain stocks, market makers can’t always sell them short” to meet that need because they must provide the borrowed shares even in less actively traded stocks, Nazarali said. “In these thin names, that’s when you need a market maker the most.”

Motors Liquidation

For instance, last year Knight wanted to sell short Motors Liquidation Co ., the firm formed to liquidate the assets of automaker General Motors Corp., which filed for bankruptcy protection in 2009. Knight couldn’t because that would have required closing out the positions by delivering shares prior to the start of trading on the sixth day after the transaction, which it couldn’t do, Nazarali said.

Motors Liquidation traded at around $1 during the middle of last year even though the equity shareholders would eventually be wiped out, Nazarali said. Because Knight and other market makers couldn’t short the shares, they weren’t able to push the price lower. The shares trade for 35 cents now.

Knight, Getco LLC and Virtu Financial LLC in July urged the SEC to adopt stricter quoting requirements for market makers than currently exist on most exchanges. New obligations should require market makers to quote at the national best bid or offer, which represents the highest price at which investors can sell shares and the lowest at which they can buy, a certain portion of the day, Nazarali said. The three firms also said market makers should submit orders at several price levels.

Investor Costs

High-frequency trading firms RGM Advisors LLC, Allston Trading LLC, Hudson River Trading LLC and Quantlab Financial LLC countered on Sept. 14 that these requirements would raise costs for investors such as mutual funds without preventing market plunges.

Market makers who meet certain quoting requirements now receive an exemption from the obligation to locate shares for stocks they want to sell short and more-lenient terms than other investors for when they must deliver shares for bearish trades.

William Neuberger, global co-head of electronic trading at Morgan Stanley in New York, said at the conference that altering the obligations and benefits for market makers won’t ensure that they stick around in difficult times to buy when investors flood them with sell orders.

“If something’s happening in the world, why should they buy stock at the wrong price when things are coming down, down, down?” he said. “Even doing that doesn’t mean there won’t be another crash. It’ll just be a slower crash. They’re going to take the fine, basically, and live.”

source Bloomberg News 2010

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 53

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 148

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 159

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 225

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 303

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 78

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 84

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 0

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 131

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Warner Bros. Discovery's Remarkable Stock Surge Explained

Updated Category News Views 309

Warner Bros. Discovery Experiences Impressive Stock Surge Warner Bros. Discovery Inc. (NASDAQ: WBD) has been making headlines recently, with its stock surging dramatically. Investors and market enthusiasts are keenly observing this upward trend, particularly following a substantial rally. Record-Breaking Rally The company achieved an incredible milestone with its largest...

Continue Reading
Stellantis Reports 20% Q3 Shipment Drop, Market Reactions

Updated Category News Views 98

Stellantis Faces Significant Q3 Shipment Decline Stellantis (EPA: STLAM) (NYSE: STLA) recently reported a 20% drop in global shipments for the third quarter, prompting a notable reaction in the markets. The decline has been attributed to several factors including strategic inventory reduction measures and delays in the release of new models. During this challenging...

Continue Reading
Stifel Affirms Buy Rating on Elanco Amid New Drug Approval

Updated Category News Views 70

Stifel Stands Firm on Elanco Animal Health Stifel, a prominent financial services firm, has recently reaffirmed its Buy rating for Elanco Animal Health (NYSE: ELAN) and has kept its price target at $20.00 per share. This decision comes on the heels of the U.S. Food and Drug Administration's (FDA) approval of Elanco's new drug, Zenrelia, which serves as a significant boost...

Continue Reading
ChargePoint and Siemens Drive EV Infrastructure Innovation

Updated Category News Views 94

ChargePoint and Siemens Lead the Charge in Clean Tech The clean tech revolution is moving at an impressive pace, particularly with the growth of electric vertical takeoff and landing (eVTOL) aircraft and electric vehicle (EV) infrastructure. Companies like ChargePoint Holdings Inc (NYSE: CHPT) and Siemens AG (OTCPK: SIEGY) are crucial in shaping a sustainable future for...

Continue Reading
Elevance Health Faces Class Action: Investors Seek Remedies

Updated Category News Views 259

Opportunities for Investors in Elevance Health Class Action The recent developments surrounding Elevance Health, Inc. have prompted considerable attention, particularly among investors who have experienced substantial financial losses. The law firm Robbins Geller Rudman & Dowd LLP has initiated a class action lawsuit targeting Elevance Health, which operates in the health...

Continue Reading